Anthony Giuffrida, MD
Physical Medicine & Rehabilitation · Fort Lauderdale, FLNPI 1740624451
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Relievant Medsystems, Inc. at 40.8% of the total. Reporting peaked in 2022 at $92,010 and has fallen 91.1% since, to $8,224 in 2025. Among physical medicine & rehabilitation clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 619 payments — averaging $437.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$110K
- MML US, Inc.$110K
- Nevro Corp.$18K
- Boston Scientific$9K
- Spinal Simplicity, LLC$8K
- Medtronic$3K
- plus $12K from 30 others
Across 9 payments — averaging $8883.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mesoblast, Inc.$67K
- MML US, Inc.$12K
Across 6 payments — averaging $15,331 each. An ownership or investment interest held by the physician or an immediate family member.
- Spinal Simplicity, LLC$92K
What the payments were for
- Consulting fees$50,61319%
- Speaking & faculty fees$153,89857%
- Travel & lodging$37,86314%
- Food & beverage$27,90010%
- Education$6000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 184 | $110,452 |
| MML US, Inc. | 166 | $110,129 |
| Nevro Corp. | 48 | $17,645 |
| Boston Scientific | 39 | $9,239 |
| Spinal Simplicity, LLC | 19 | $8,005 |
| Medtronic(2 entities) | 42 | $3,096 |
| Interventional Pain Technologies Inc. | 4 | $2,563 |
| Lenoss Medical Inc | 3 | $2,213 |
| Stryker | 13 | $1,458 |
| Abbott | 20 | $1,115 |
| Averitas Pharma Inc. | 7 | $731 |
| Vertiflex, Inc. | 9 | $645 |
| Saluda Medical Americas, Inc. | 8 | $564 |
| Johnson & Johnson | 9 | $456 |
| Globus Medical(2 entities) | 9 | $416 |
| Foundation Fusion Solutions, LLC | 1 | $368 |
| Nalu Medical, Inc. | 3 | $360 |
| Stimwave Technologies Incorporated | 10 | $333 |
| Vertos Medical, Inc. | 3 | $289 |
| Curonix LLC | 2 | $126 |
| Stratus Medical, LLC | 1 | $122 |
| Amgen | 4 | $93 |
| Biocomposites Inc | 1 | $90 |
| SPR Therapeutics, Inc | 1 | $70 |
| Orthofix Medical, Inc. | 1 | $50 |
| Vertex | 2 | $48 |
| Pacira Pharmaceuticals Incorporated | 1 | $33 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| GRT US Holding, Inc. | 1 | $24 |
| KCI USA, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $18 |
| The Institute Of Musculoskeletal Science And Education | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| Si-bone, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$194,255
- ReActiv8$106,664
- Senza$9,123
- Vyrsa V1$8,040
- HA MINUTEMAN G3-R$7,811
- Omnia$2,425
- Access & Cavity Creation Kit$2,213
- OSTEOCOOL RF ABLATION$1,185
- INTELLIS$827
- mild Device Kit$573
- AUGMENT INJECTABLE$537
- Qutenza$446
- PROCLAIM$402
- Superion ISS$352
- Nalu Neurostimulation System$345
- Evoke SCS$269
- GENERAL PAIN MANAGEMENT$255
- Superion Indirect Decompression System$137
- OPTABLATE$132
- TLIF$131
How this compares
$270,873 in reported general payments places this provider in the 95th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 106 | $1,374 |
| Meloxicam | 309 | $1,013 |
| Methocarbamol | 178 | $892 |
| Tizanidine Hcl | 22 | $123 |
| Methylprednisolone | 23 | $107 |
| Tramadol Hcl | 30 | $39 |
| Diazepam | 30 | $37 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Fort Lauderdale
- Roshan ChhatlaniFort Lauderdale$13K
- Ryan HafnerSarasota$164K
- Cassandra ListJacksonville$154K
- Marissa McCarthyTampa$94K
- Jose Medina SanchezTampa$30K
- Alan MillerFernandina Beach$26K
- Anish SoniNaples$25K
- Jose de la TorreWesley Chapel$23K
- Kaivalya DeshpandeMiami$22K
- Ryan RamsookTallahassee$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.